Cargando…
Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study
BACKGROUND: The clinical implications of potential interactions between proton pump inhibitors (PPIs) and clopidogrel have been debated for over a decade. OBJECTIVE: We assessed the association between combined clopidogrel–PPI treatment and the risk of recurrent myocardial infarction (MI) and three...
Autores principales: | Farhat, Nawal, Birkett, Nicholas, Haddad, Nisrine, Fortin, Yannick, Momoli, Franco, Wen, Shi Wu, Wielgosz, Andreas, McNair, Doug S., Mattison, Donald R., Krewski, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392938/ https://www.ncbi.nlm.nih.gov/pubmed/32617885 http://dx.doi.org/10.1007/s40801-020-00204-9 |
Ejemplares similares
-
Systemic quinolones and risk of retinal detachment III: a nested case–control study using a US electronic health records database
por: Taher, Mohamed Kadry, et al.
Publicado: (2022) -
Systemic quinolones and risk of acute liver failure III: A nested case–control study using a US electronic health records database
por: Taher, Mohamed Kadry, et al.
Publicado: (2021) -
External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality
por: Fortin, Yannick, et al.
Publicado: (2017) -
Off-label use of cancer therapies in women diagnosed with breast cancer in the United States
por: Hamel, Sophie, et al.
Publicado: (2015) -
Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence
por: Mistry, Suresh D., et al.
Publicado: (2011)